Thalia Therapeutics Balance Sheet

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	1.08	0.63	1.03	1.92	1.78
Cash & Short-Term Investments	1.08	0.63	1.03	1.92	1.78
Cash Growth	72.42%	-39.05%	-46.49%	7.60%	-49.83%
Accounts Receivable	0.09	0.15	0.19	0.25	0.56
Total Current Assets	1.17	0.78	1.21	2.17	2.34
Goodwill	-	-	0.06	-	-
Total Assets	1.17	0.78	1.28	2.17	2.34
Accounts Payable	-0.03	-0.03	-0.03	-0.04	-0.18
Accrued Expenses	-0.07	-0.1	-0.06	-0.04	-0.03
Total Current Liabilities	-0.1	-0.12	-0.08	-0.08	-0.21
Total Liabilities	-0.1	-0.12	-0.08	-0.08	-0.21
Common Stock	11.6	9.85	9.35	9.21	9
Additional Paid-in Capital	15.17	15.33	15.26	15.08	14.3
Accumulated Other Comprehensive Income	-14.14	-14.14	-14.14	-14.14	-14.14
Retained Earnings	-11.56	-10.4	-9.34	-8.06	-7.03
Total Common Shareholders' Equity	1.07	0.65	1.13	2.09	2.13
Minority Interest	0	0	0.07	-	-
Shareholders' Equity	1.07	0.65	1.19	2.09	2.13
Total Liabilities & Equity	0.97	0.53	1.11	2.01	1.92
Net Cash (Debt)	1.08	0.63	1.03	1.92	1.78
Net Cash Growth	72.42%	-39.05%	-46.49%	7.60%	-49.83%
Net Cash Per Share	0.00	0.00	0.00	0.01	0.01
Book Value	1.07	0.65	1.13	2.09	2.13
Book Value Per Share	0.00	0.00	0.00	0.01	0.01
Tangible Book Value	1.07	0.65	1.07	2.09	2.13
Tangible Book Value Per Share	0.00	0.00	0.00	0.01	0.01